Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

IDM Pharma, Inc. (NASDAQ:IDMI.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on developing innovative products to treat and control cancer while maintaining the patient's quality of life.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:IDMI.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

hleason (< 20)
Submitted May 02, 2007

But MTPPE, JUVANAN, is due for FDA panel review on 5/9/07. I believe that they will recommend approval. The stock should sell up big on this news, maybe 20+. It may cool a little after that, but maybe not. JUVANAN is MTPPE and showed a survival… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:IDMI.DL VS S&P 500 (SPY)

NASDAQ:IDMI.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about IDMI.DL.

No one has written a Pitch for IDMI.DL stock yet. Tell us why you think IDMI.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in IDMI.DL.

No players have picked IDMI.DL yet. Tell us why you think IDMI.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for IDMI.DL.